United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Product Type (Cardiac Monitoring Devices, Cardiac Rhythm Management Device), By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

The United States Cardiac Monitoring & Cardiac Rhythm Management Devices market was valued at USD 3.70 Billion in 2024 and is expected to reach USD 5.13 Billion by 2030 with a CAGR of 5.55%. Cardiac Monitoring and Cardiac Rhythm Management Devices are indispensable medical technologies used in the diagnosis, treatment, and management of heart diseases. Cardiac Monitoring devices play a crucial role in tracking the heart's electrical activity and identifying any abnormal rhythms, known as arrhythmias, which can serve as indicators of underlying heart conditions. These devices, including ECG (Electrocardiogram) machines, Holter monitors, and event monitors, enable physicians to continuously observe and assess the heart's function over an extended period of time, providing valuable insights into the patient's heart health. Cardiac Rhythm Management Devices are specifically designed to manage heart rhythm disorders. These devices, such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, are instrumental in correcting irregular heart rhythms, preventing sudden cardiac arrest, and improving the coordination of heartbeats in patients with heart failure. By delivering electrical impulses or shocks to the heart, these devices effectively restore and maintain normal heart rhythm, ultimately enhancing the quality of life for individuals living with heart disease.

Both types of devices, Cardiac Monitoring and Cardiac Rhythm Management Devices, play a critical role in not only diagnosing and treating heart diseases but also in effectively managing and maintaining heart health. With their advanced technologies and continuous monitoring capabilities, they provide healthcare professionals with essential tools to optimize patient care and improve clinical outcomes in the field of cardiology.

Key Market Drivers

Growing Burden of Cardiovascular Disorders

The escalating burden of cardiovascular disorders in the United States is expected to significantly propel the demand for cardiac monitoring and cardiac rhythm management devices. Cardiovascular disease (CVD) remains the leading cause of mortality across nearly all racial and ethnic demographics in the United States, underscoring its broad and disproportionate health impact. Current estimates indicate that 1 in 3 American adults is living with at least one form of CVD, including conditions such as coronary artery disease, stroke, or heart failure. Alarmingly, the nation loses one life to cardiovascular complications every 33 seconds, placing immense strain on hospital emergency departments, intensive care units, and long-term care services. These devices play a pivotal role in tracking heart function, enabling the early detection of irregular rhythms and conditions that may lead to severe cardiovascular issues. Such proactive diagnosis and management can mitigate the risk of fatal events, accentuating the importance of these devices. Moreover, the aging population, prevalent lifestyle diseases like obesity and diabetes, and the ever-increasing stress levels further contribute to growing cardiovascular disorders, thereby augmenting the need for advanced cardiac care. As healthcare centers strive to offer superior care, the adoption of cardiac monitoring and rhythm management devices is anticipated to see a surge. Therefore, these circumstances collectively signify a potential rise in the demand for these crucial devices in the United States.

Technological Advancements

The advent of cutting-edge technology in the medical field, specifically in cardiac monitoring and cardiac rhythm management devices, is expected to bolster demand in the United States. As the prevalence of cardiovascular diseases surges, there is an urgent need for advanced, efficient, and accessible cardiac monitoring systems. Technological advancements, such as the integration of artificial intelligence and machine learning, are enhancing the precision and predictive capabilities of these devices, thus increasing their adoption. Moreover, the development of remote patient monitoring technologies enables healthcare providers to track a patient's cardiac rhythm in real-time, leading to timely intervention and improved patient outcomes. The proliferation of wearable technology and smart devices, coupled with growing health awareness among consumers, further fuels the demand. Technological innovation is also driving the miniaturization of these devices, improving patient comfort and ease of use. Moreover, the ongoing research and development activities, supported by substantial investments, are anticipated to introduce breakthrough products, thereby stimulating market growth. Consequently, the intersection of technology and cardiac care is set to reshape the landscape of cardiac monitoring and rhythm management devices, amplifying their demand in the US healthcare sector.

Rise In the Use of Ambulatory and Home Services for Cardiac Monitoring

The rise in the utilization of ambulatory and home services for cardiac monitoring is anticipated to propel the demand for Cardiac Monitoring & Cardiac Rhythm Management Devices (CM & CRM) in the United States. In 2022, the U.S. healthcare system recorded approximately 12.4 million ambulatory surgery encounters and 16.4 million surgical procedures conducted in outpatient settings, reflecting the sector’s growing shift toward high-efficiency, lower-cost care models. Ambulatory services now serve as a cornerstone of hospital operations, encompassing a wide range of non-emergency interventions from routine health assessments and prenatal examinations to minor surgical procedures and targeted treatment for acute conditions. This surge is attributed to an elevated consciousness about cardiovascular diseases and the benefits of early diagnosis. The continuous monitoring facilitated by these devices, especially in home and ambulatory settings, ensures the prompt detection of any cardiac anomalies, thereby aiding in the timely treatment. This, in turn, safeguards patients from potential severe cardiac events. Furthermore, the advent of advanced, user-friendly, and non-invasive CM & CRM devices, with features such as remote monitoring, has made them more accessible to patients. They have proven useful especially for the elderly and those with mobility constraints. Additionally, the ongoing pandemic has underscored the importance of remote healthcare services, further escalating the demand for home-based and ambulatory cardiac monitoring solutions. Thus, the growing prevalence of cardiac diseases combined with the rise in the adoption of remote healthcare solutions is expected to drive the market for CM & CRM devices in the U.S.

Healthcare Infrastructure Development

The development of healthcare infrastructure stands as a significant driver for increasing the demand for Cardiac Monitoring and Cardiac Rhythm Management (CRM) Devices in the United States. As the U.S continues to invest in modernizing healthcare facilities, there is a growing emphasis on ergonomics, technical advancements, and patient comfort. This translates into an increased need for sophisticated cardiac monitoring systems and CRM devices to ensure accurate assessment, timely intervention, and effective treatment. Moreover, the prevalence of cardiovascular diseases, driven by an aging population and lifestyle-related factors, necessitates the establishment of well-equipped healthcare settings with state-of-the-art cardiac devices. Such devices not only facilitate the early detection of cardiac disorders but also manage the cardiac rhythm in patients with irregular heartbeats. Additionally, the federal government's push for a robust digital health ecosystem encourages the adoption of advanced technologies, including remote patient monitoring and telemedicine, further escalating the demand for these cardiac devices. Therefore, as healthcare infrastructure develops, the demand for cardiac monitoring and CRM devices is projected to surge, enhancing patient outcomes and transforming cardiac care in the U.S.

Download Free Sample Report

Key Market Challenges

Effects of Therapeutic Radiation on Implantable Cardiac Rhythm Devices

Therapeutic radiation, a common treatment for various forms of cancer, has shown to adversely affect the functionality of Implantable Cardiac Rhythm Devices (ICRDs), such as pacemakers and defibrillators. This interference can lead to unpredictable and potentially life-threatening situations for patients relying on these devices. As a result, there is an emerging trend in the United States of decreasing demand for these Cardiac Monitoring & Cardiac Rhythm Management Devices. Patients are now seeking alternative treatment options or technologies that are resistant to radiation effects, a shift driven by the potential risks posed by the interaction of radiation therapy and ICRDs. Furthermore, healthcare providers are becoming increasingly aware of these risks and are therefore advising patients accordingly. This trend is likely to continue, especially as advancements in medical technology pave the way for new, safer, and more reliable cardiac management solutions. Consequently, the demand for traditional Cardiac Monitoring & Cardiac Rhythm Management Devices might continue to decrease in the forthcoming years.

High Cost of Devices

The high cost of cardiac monitoring and cardiac rhythm management devices is anticipated to diminish demand in the United States. For the average American, healthcare expenses are a significant concern, and the steep price of these advanced devices can serve as a deterrent. Many of these devices, including implantable cardioverter-defibrillators (ICDs), pacemakers, and cardiac resynchronization therapy (CRT) devices, are often beyond the financial reach of patients without substantial insurance coverage. Additionally, the cost burden extends beyond the initial purchase, encompassing maintenance, potential replacement, and healthcare visits associated with the devices. Economic disparities across different regions and communities further exacerbate the issue, making these devices inaccessible to those in lower socioeconomic groups. While these devices undoubtedly offer potential life-saving benefits, the high cost poses a significant barrier to their widespread adoption. Therefore, it is crucial for manufacturers and healthcare providers to address this issue, perhaps by exploring cost reduction strategies, implementing flexible payment plans, or advocating for more comprehensive insurance coverage for these devices.

Key Market Trends

Rising Demand for Minimally Invasive Procedures

The rising demand for minimally invasive procedures is anticipated to fuel an increased demand for Cardiac Monitoring & Cardiac Rhythm Management Devices within the United States. Minimally invasive procedures, with their hallmark of smaller incisions, reduced hospital stays, and a lower risk of complications, have revolutionized the field of cardiac care. As healthcare providers strive to ensure efficient patient outcomes and patient comfort, these procedures have become an increasingly popular choice. This shift is bolstering the demand for associated devices, crucial in the monitoring and management of cardiac rhythms in these procedures. Sophisticated devices such as Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy Devices (CRTs), and pacemakers are especially significant in monitoring the heart's electrical activity, regulating heart rhythms, and preventing heart failures. The American heart disease landscape, characterized by an aging population and a high prevalence of heart-related disorders, further contributes to this demand. Hence, the surge in minimally invasive cardiac procedures is expected to act as an impetus for growth in the Cardiac Monitoring & Cardiac Rhythm Management Devices market in the United States.

Increasing Investments in R&D

Increasing investments in Research and Development (R&D) are expected to drive the demand for Cardiac Monitoring & Cardiac Rhythm Management Devices in the United States. The country's escalating healthcare expenditure coupled with a growing aging population prone to cardiac ailments necessitates such technological advancements in cardiac care. As R&D funding escalates, promising advancements are on the horizon, including devices with enhanced functionalities and precision, leading to improved patient outcomes. Innovations in wireless remote monitoring systems and wearable technologies also present significant growth opportunities. Furthermore, the rise in incidences of cardiac disorders and the growing awareness about early diagnosis and treatment are propelling demand for these devices. The robust regulatory environment that encourages R&D, paired with venture capital enthusiasm for health technology, also contributes to this upward trend. In addition, the proliferation of Artificial Intelligence (AI) and Machine Learning (ML) in healthcare sector is expected to revolutionize the capabilities of Cardiac Monitoring & Cardiac Rhythm Management Devices, delivering precise and personalized patient care. Ultimately, these factors combined are poised to fuel an increased demand for such devices in the US, further strengthening its market position globally.

Segmental Insights

Product Type Insights

Based on the Product Type, Cardiac Monitoring Devices (CMD) segment emerges as the fastest growing segment in the United States Cardiac Monitoring and Cardiac Rhythm Management Devices Market. The increasing prevalence of cardiovascular conditions such as atrial fibrillation, heart failure, ischemic heart disease, and hypertension has created sustained demand for early detection and continuous cardiac surveillance. In the United States, heart failure (HF) currently affects an estimated 1.9% to 2.6% of the adult population, equating to approximately 6.7 million individuals aged 20 and above. This already substantial disease burden is on a clear upward trajectory, with forecasts indicating that the number of Americans living with HF will rise to 8.5 million by 2030 and reach 11.4 million by 2050. Cardiac monitoring devices such as electrocardiograms (ECG), Holter monitors, event monitors, and mobile cardiac telemetry (MCT) systems play a pivotal role in diagnosing and tracking arrhythmias and abnormal cardiac rhythms before they escalate into life-threatening events.

The U.S. healthcare ecosystem is experiencing a strategic transition from reactive treatment to preventive and value-based care. In this context, cardiac monitoring devices are gaining traction as essential tools for remote patient monitoring (RPM) and chronic disease management. These devices enable early identification of risk factors, reduce emergency admissions, and allow physicians to optimize treatment regimens based on real-time cardiac data. The integration of wearable biosensors, smartphone-enabled ECGs, patch-based monitors, and AI-powered diagnostics has revolutionized the cardiac monitoring segment. Devices such as single-lead ECG patches and multi-day Holter monitors are now more compact, user-friendly, and capable of wirelessly transmitting patient data to healthcare providers. This level of innovation has significantly improved patient compliance, data accuracy, and diagnostic yield, fueling adoption in both clinical and consumer health settings.

Download Free Sample Report

Regional Insights

Based on region, The Western region of the United States emerged as the largest market in the Cardiac Monitoring and Cardiac Rhythm Management Devices Market. The Western U.S. including states like California, Arizona, and Washington has a significant population burdened by lifestyle-related conditions such as obesity, diabetes, and hypertension, which are major risk factors for arrhythmias and heart failure. This epidemiological trend directly contributes to rising demand for both cardiac monitoring devices (e.g., Holter monitors, ECG devices) and CRM devices (e.g., pacemakers, implantable cardioverter defibrillators).

The region boasts some of the nation’s most advanced healthcare infrastructures, including world-class academic hospitals, integrated delivery networks, and specialized cardiovascular centers. These institutions are early adopters of next-generation CRM devices such as wireless implantables, remote telemetry systems, and AI-enabled diagnostic tools. Their capacity to offer complex cardiac interventions enhances both procedural volume and device penetration. States in the West tend to have progressive healthcare policies and higher private insurance coverage, which facilitates better patient access to high-cost cardiac devices. Moreover, initiatives supporting value-based care and digital health monitoring platforms promote the use of long-term remote monitoring solutions, thereby increasing utilization of ambulatory cardiac telemetry and mobile cardiac outpatient telemetry (MCOT) systems.

Recent Developments

• In April 2025, Medtronic plc, has received U.S. FDA approval for its OmniaSecure defibrillation lead, designed for implantation in the right ventricle. Leveraging the proven reliability of the SelectSecure Model 3830 pacing lead platform, the OmniaSecure lead is delivered via a catheter-based approach, enabling precise, minimally invasive placement within the cardiac anatomy.
• In November 2024, Johnson & Johnson MedTech has received U.S. FDA approval for its VARIPULSE™ Pulsed Field Ablation (PFA) platform, marking a significant advancement in the treatment of atrial fibrillation (AFib). The VARIPULSE™ system utilizes a non-thermal energy approach to selectively target and ablate cardiac tissue responsible for abnormal electrical signals, while minimizing damage to surrounding structures such as the esophagus or phrenic nerve. This approval underscores Johnson & Johnson’s strategic focus on next-generation electrophysiology solutions that offer enhanced safety, procedural efficiency, and clinical precision in the management of complex arrhythmias.
• In October 2023, Medtronic plc has secured U.S. FDA approval for its Aurora EV-ICD™ MRI SureScan™ system and Epsila EV™ MRI SureScan™ defibrillation lead, marking a significant advancement in the treatment of life-threatening cardiac arrhythmias. Designed to prevent sudden cardiac arrest (SCA) caused by dangerously rapid heart rhythms, the Aurora EV-ICD is the first extravascular implantable cardioverter-defibrillator system to deliver the clinical effectiveness of traditional transvenous ICDs, while utilizing a lead placed beneath the sternum outside the heart and vascular system. This next-generation design reduces the risk of bloodstream infections and vascular complications, positioning Medtronic at the forefront of innovation in cardiac rhythm management.
• In October 2023, Abbott (NYSE: ABT) has received U.S. FDA clearance for its Assert-IQ™ insertable cardiac monitor (ICM), expanding the company’s portfolio of connected cardiovascular diagnostics. The Assert-IQ™ offers physicians a new-generation tool for continuous, long-term monitoring and diagnostic assessment of patients with suspected cardiac arrhythmias, such as atrial fibrillation and other irregular heart rhythms.

Key Market Players

• Abbott Laboratories, Inc.
• Medtronic USA, Inc.
• Boston Scientific Corporation
• GE Healthcare
• Philips Healthcare (USA)
• Hill-Rom Holdings, Inc.
• BIOTRONIK, Inc.
• Alivecor, Inc.

Report Scope:

In this report, the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Product Type:

o   Cardiac Monitoring Devices

o   Cardiac Rhythm Management Device

• United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User:

o   Hospitals & Clinics

o   Cardiac Care Centers

o   Ambulatory Surgery Centers

o   Others

• United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Region:

o   Northeast Region

o   Midwest Region

o   West Region

o   South Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market.

Available Customizations:

United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]